Cargando…
A New England COVID-19 Registry of Patients With CNS Demyelinating Disease: A Pilot Analysis
BACKGROUND AND OBJECTIVES: We sought to define the risk of severe coronavirus disease 2019 (COVID-19) infection requiring hospitalization in patients with CNS demyelinating diseases such as MS and the factors that increase the risk for severe infection to guide decisions regarding patient care durin...
Autores principales: | Money, Kelli M., Mahatoo, Ashmanie, Samaan, Soleil, Anand, Pria, Baber, Ursela, Bailey, Mary, Bakshi, Rohit, Bouley, Andrew, Bower, Aaron, Cahill, Jonathan, Houtchens, Maria, Katz, Joshua, Lathi, Ellen, Levit, Elle, Longbrake, Erin E., McAdams, Matthew, Napoli, Salvatore, Raibagkar, Pooja, Wade, Peter, Sloane, Jacob A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8362350/ https://www.ncbi.nlm.nih.gov/pubmed/34341094 http://dx.doi.org/10.1212/NXI.0000000000001046 |
Ejemplares similares
-
Blunted Post-COVID-19 Humoral Immunity in Patients With CNS Demyelinating Disorders on Anti-CD20 Treatments
por: Money, Kelli M., et al.
Publicado: (2022) -
Brainstem lesions are associated with sleep apnea in multiple sclerosis
por: Levit, Elle, et al.
Publicado: (2020) -
Seroconversion after COVID-19 vaccination for multiple sclerosis patients on high efficacy disease modifying medications
por: Levit, Elle, et al.
Publicado: (2022) -
Challenges in the diagnosis and treatment of CNS demyelinating disorders in Zambia
por: Miskin, Dhanashri P, et al.
Publicado: (2016) -
Case Report: Anti-NMDAR Encephalitis With Anti-MOG CNS Demyelination After Recurrent CNS Demyelination
por: Ren, Bing-Yan, et al.
Publicado: (2021)